Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. - Wikidata - awgldk - TriplyDB

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

http://www.wikidata.org/entity/Q34980413

about

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.TERT Promoter Mutations and Risk of Recurrence in Meningioma.Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.Classification of human meningiomas: lights, shadows, and future perspectives.The anti-apoptotic protein survivin can improve the prognostication of meningioma patients.Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.Meningioma growth dynamics assessed by radiocarbon retrospective birth dating.MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.Systemic therapy for recurrent meningioma.Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes.A gene expression signature predicts recurrence-free survival in meningioma.

P2860

Q27853347-3BB1AEB8-45D3-4ABA-9C8A-67FC2E6793B0 Q35204658-7BE0032A-8368-4295-B720-970FFAD9418B Q35788622-6B2A295D-994A-4A7D-8850-9AA03EA11440 Q36705923-1FD54AAB-0F3B-4F17-B0E6-6270D9075ADD Q36849156-995F3001-54C5-4FE7-B1E9-C97456D6A5A3 Q37564326-D4E96278-8452-469B-8058-A7A18AECB918 Q38810583-A15ACE51-EC20-4495-B8CD-99DA6A0AE945 Q41973584-A188630B-A1C9-4B8D-B753-00628AA94967 Q42397459-27A3CCF1-CCC3-4B99-BAB5-9C6F7002FD22 Q46129842-32CF9BF2-84E8-4E8C-B5B2-67422FC58B4F Q46447234-3F98778D-D81A-403B-998A-22ED0C36AC42 Q47174165-35B3CFB1-C8EF-4D06-8BCC-4EA607DC7259 Q48211092-83D26B6A-69B0-426A-8269-208F3D403755 Q48302173-473678DC-F2BC-49FE-BBE1-BB984523D2BA Q48787594-7C6A3EC6-5233-4602-AA7F-51E13E545729 Q51448302-FFCA5515-315A-44D6-820E-0A52655128A0 Q52145213-3314470D-D8DB-45F1-A2E5-D35D68A63CF2 Q52584358-3EC3A7A8-6E7A-4D7C-87F0-4908C3270000

P2860

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

http://www.wikidata.org/entity/Q34980413

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@ast

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@en

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@nl

type

label

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@ast

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@en

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@nl

prefLabel

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@ast

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@en

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

@nl

P1433

Q34980413-1AA580E9-A992-4EA1-86E9-971540E0FC3A

P1476

Q34980413-25CC8DF3-DD0A-446B-AE2C-89A3A7398845

P2093

Q34980413-1C26CE69-05AA-405A-B4C9-94A1DECEC7AC

Q34980413-31CD98AC-2FF6-44BC-83E9-49CC6186BAAE

Q34980413-6C227465-C565-42D8-986B-14AE2153C896

Q34980413-7C393683-4FB5-49C0-8A94-8E75B9EB1E7F

Q34980413-BE91E304-9081-413C-B3A5-FC89E3FB4C9E

Q34980413-C39C16EA-2316-4610-A5ED-0BCFE9C694B4

Q34980413-EC721755-ED27-4313-B1A5-808536059C95

Q34980413-F8C86479-9E8E-48C7-A967-68064D2AD325

P2860

Q34980413-03FA07F1-7E19-4472-9A55-18FDD2B3DF51

Q34980413-08EDFDC5-E604-470B-B6E8-1FF1D78ECE3C

Q34980413-243B00B8-C275-4A92-9BB1-3A9B4A0CB0BB

Q34980413-255D7466-BE1A-4E2B-942C-544D90D36CBD

Q34980413-3834A133-A35E-4C74-912B-361D35ACC981

Q34980413-3A6E14D7-D69B-45ED-AA3E-7404F46FB6E5

Q34980413-3E11B25D-9F84-4ED9-BB4B-219938B8F873

Q34980413-3E465DE7-3C1B-462E-9509-FB32EB0FBC9C

Q34980413-41B28BA7-CFE5-4CA4-A5D9-100B0EAA854B

Q34980413-44575930-5655-485E-9C50-E1967B7C0490

P304

Q34980413-A76372EC-8891-4C1F-B56E-E7E58706253F

P31

Q34980413-AECEAE3C-5817-4E93-B7D0-EA5910DFC976

P356

Q34980413-B9B4FB5C-6FAE-478E-BD24-ED9C7FEC7C27

P433

Q34980413-15294C44-4293-4F24-87E4-5A6BC969118F

P478

Q34980413-AF867E81-9392-4743-B484-24E63A75F61F

P50

Q34980413-188F7D59-1D11-4BAE-A278-6224A8F035F5

P577

Q34980413-4C7A62A9-FEA8-434D-A61C-AB2C14525717

P698

Q34980413-18069036-F511-4D78-91F7-B289865F99FE

P932

Q34980413-CE6F4C2C-B963-4E7D-B1BE-A18510E20AB8

P356

P1433

Brain Pathology

P1476

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma

@en

P2093

Adriana Olar

http://www.w3.org/2001/XMLSchema#string

Alireza Mansouri

http://www.w3.org/2001/XMLSchema#string

Charmaine D Wilson

http://www.w3.org/2001/XMLSchema#string

Erik P Sulman

http://www.w3.org/2001/XMLSchema#string

Franco DeMonte

http://www.w3.org/2001/XMLSchema#string

Gelareh Zadeh

http://www.w3.org/2001/XMLSchema#string

Kenneth D Aldape

http://www.w3.org/2001/XMLSchema#string

Khalida M Wani

http://www.w3.org/2001/XMLSchema#string

P2860

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Detecting novel associations in large data sets.

The recurrence of intracranial meningiomas after surgical treatment

Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.

Clinical and radiological features related to the growth potential of meningioma.

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study

Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up

Impaired survival and long-term neurological problems in benign meningioma.

P304

266-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPA.12174

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25040885

http://www.w3.org/2001/XMLSchema#string

P932

4297750

http://www.w3.org/2001/XMLSchema#string